- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03383562
Daytime Variation of Complication in Gastric and Pancreatic Surgery
Daytime Variation of Complication in Gastric and Pancreatic Surgery : a Single Center Randomized Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The trial is funded by Cancer Foundation of China. The trial is prepared to be registered on the clinicaltrails.gov. Quality assurance plan: every participant is enrolled or excluded by two practiced investigators. And two investigators participated in all steps of the trail, including the record of the data, and the investigators will compare the data. If the data is consistent, the investigators would record the data; if not, the data would be checked and decided by the two investigators. All the steps and data are site monitored and audited by the workers of research and financial department of National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences. Data check: the investigators compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry. Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources, including medical records and electronic case report forms. Data dictionary that contains detailed descriptions of each variable used by the registry, including the source of the variable, coding information, and normal ranges if relevant.
Standard Operating Procedures to address registry operations and analysis activities, such as participants recruitment, data collection, data management, data analysis, reporting for adverse events, and change management. All registry operations would be done according to specific steps, and by two practiced investigators. Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect. According to the formula to differ advantages and disadvantages, the investigators need at least 200 participants to take part in the trail.
The investigators can recruit about 600 participants every year according to previous experiences, so the investigators should recruit at least for half a year. Plan for missing data: the investigators would collect as much data as possible, and the investigators exclude the participants who cannot cooperate on recruitment. And the investigators manage situations according to statistical principles where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results. Statistical analysis plan: Kaplan-Meier method would be used to analyze the difference of complications between the three groups, and the local control rate of the three groups would be compared by chi square test. Statistical analyses would be performed by using International Business Machine Statistical Product and Service Solutions Statistics(version 20; IBM, Chicago, USA). The level of significance is defined as P < 0.05.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who will undergo gastric or pancreatic surgery in our department.
- Voluntary participation, Signing informed consent and have good compliance.
Exclusion Criteria:
- Patient who attended other clinical trials in the last two months.
- Patient who will undergo multiple organs resection.
- Patient who has been taken anticoagulant recently.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
morning group
patients in the morning group are operated during 8:30 a.m. to 2:00 p.m.
|
operation was arranged in the morning ,afternoon or at night
|
|
afternoon group
patients in the morning group are operated during 2:00 p.m. to 8:00 p.m.
|
operation was arranged in the morning ,afternoon or at night
|
|
night group
patients in the morning group are operated during 8:00 p.m. to 12:00 p.m.
|
operation was arranged in the morning ,afternoon or at night
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
gastrointestinal dysfunction
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks
|
using clinical symptoms to evaluate the gastrointestinal function after surgery
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks
|
|
hemorrhage
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
using clinical symptoms to evaluate the gastrointestinal function after surgery
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
|
infection
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
using clinical symptoms to evaluate the gastrointestinal function after surgery
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
|
anastomotic fistula
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks
|
using clinical symptoms to evaluate the gastrointestinal function after surgery
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks
|
|
test rating
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
collecting blood sample to evaluate change of test after surgery
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first, up to 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical fitness index
Time Frame: after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks.
|
The recovery of physical fitness index
|
after operation from date of randomization until the date of first documented complications or date of death from any cause, whichever came first,up to 24 weeks.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chengfeng Wang, B.A., Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CT20180101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.